EcoDrugPlus

Tyrosine-Protein Kinase Jak2-Like

Ensembl ID : ENSHCOG00000007876
Gene Symbol: LOC109519569
2 Cross references
194 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSHCOG00000016241
Gene Symbol: LOC109515497
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Fyna

Ensembl ID : ENSHCOG00000020626
Gene Symbol: LOC109517462
3 Cross references
191 Possible Orthologues:

Tyrosine-Protein Kinase Yes

Ensembl ID : ENSHCOG00000006086
Gene Symbol: LOC109531819
3 Cross references
206 Possible Orthologues:

Uncharacterized Loc109511462

Ensembl ID : ENSHCOG00000003623
Gene Symbol: LOC109511462
2 Cross references
191 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSHCOG00000018844
Gene Symbol: UTS2R
4 Cross references
97 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSHCOG00000012434
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:

Vascular Endothelial Growth Factor A-A-Like

Ensembl ID : ENSHCOG00000021159
Gene Symbol: LOC109521925
3 Cross references
181 Possible Orthologues:

Vitamin D Receptor

Ensembl ID : ENSHCOG00000005359
Gene Symbol: VDR
1 Cross references
388 Possible Orthologues:

Vitamin D3 Receptor B

Ensembl ID : ENSHCOG00000010402
Gene Symbol: LOC109522239
3 Cross references
392 Possible Orthologues:

Vitamin K Epoxide Reductase Complex Subunit 1-Like Protein 1

Ensembl ID : ENSHCOG00000000509
Gene Symbol: LOC109524007
3 Cross references
190 Possible Orthologues:

Voltage-Dependent L-Type Calcium Channel Subunit Alpha-1d-Like

Ensembl ID : ENSHCOG00000006839
Gene Symbol: LOC109522320
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).